Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Children with epidermal differentiation disorders (EDDs) lag behind in weight and height during their first two years of life, but new research shows the long-term outlook depends heavily on their specific genetic variant. Kids with SPINK5 mutations face persistent growth deficits with no catch-up by age 18, while those with ABCA12 or KRT10 variants tend to normalize after age 2. Routine growth monitoring and multidisciplinary care are strongly recommended.
Children diagnosed with epidermal differentiation disorders (EDDs) — a group of rare genetic skin conditions — show meaningful growth deficits in their first two years of life, but whether those deficits persist depends largely on which gene is affected. A new study published in JAMA Dermatology tracked growth data from 135 children with confirmed EDDs from birth through age 18, comparing them against standard CDC and WHO growth references.
Overall, children with EDDs had average weight at the 31st percentile and height at the 39th percentile during the first 24 months — both significantly below population norms. But the story diverges sharply by genotype after that.
By the Numbers:
Why it matters: For clinicians managing children with EDDs, these findings underscore that growth monitoring can't be one-size-fits-all. Genotype-specific surveillance — especially for SPINK5 variants — is critical, as these children may need early, sustained intervention to address lifelong growth failure risks.
